Publications by authors named "Luckson Mathieu"

Claim this Profile
F
FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC.
Luckson N Mathieu, Erin Larkins, Arup K Sinha, Pallavi S Mishra-Kalyani, Samina Jafri

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf, Luckson N Mathieu, Yi Ren

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations.
Luckson N Mathieu, Erin Larkins, Oladimeji Akinboro, Pourab Roy, Anup K Amatya

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, Erin Larkins, Jonathon Vallejo

Oncologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring Mutations.
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, Erin Larkins, Kirsten B Goldberg

Oncologist· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, Gideon M Blumenthal, Erin Larkins

Oncologist· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma.
Mridul Agrawal, Jennifer Kanakry, Christina A Arnold, Daniel L Suzman, Luckson Mathieu

Ann Hematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after community diagnosis of early-stage non-small cell lung cancer.
Norma F Kanarek, Craig M Hooker, Luckson Mathieu, Hua-Ling Tsai, Charles M Rudin

Am J Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis